Publication Name	World Journal of Diabetes
Manuscript ID	86182
Country	United States

Received	2023-06-09 11:10
Peer-Review Started	2023-06-09 11:13
To Make the First Decision
Return for Revision	2023-07-18 07:58
Revised	2023-07-31 22:02
Second Decision	2023-08-21 00:23
Accepted by Journal Editor-in-Chief	2023-08-21 13:15
Accepted by Company Editor-in-Chief	2023-08-28 16:48
Articles in Press	2023-08-28 16:48
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2023-09-07 07:30
Publish the Manuscript Online	2023-10-09 11:18

ISSN	1948-9358 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Endocrinology & Metabolism
Manuscript Type	Minireviews
Article Title	Gut microbiome supplementation as therapy for metabolic syndrome
Manuscript Source	Invited Manuscript
All Author List	Mc Anto Antony, Aniqa Chowdhury, Dinesh Edem, Rishi Raj, Priyanshu Nain, Mansi Joglekar, Vipin Verma and Ravi Kant
ORCID	Author(s) ORCID Number Mc Anto Antony http://orcid.org/0000-0002-2232-0078 Dinesh Edem http://orcid.org/0000-0002-4151-3246 Ravi Kant http://orcid.org/0000-0002-9599-8082
Funding Agency and Grant Number
Corresponding Author	Mc Anto Antony, MD, Staff Physician, Department of Endocrinology, Diabetes and Metabolism, Medical University Of South Carolina/AnMed Campus, 2000 E Greenville St Suite 3100, Anderson, SC 29621, United States. drmcanto@gmail.com
Key Words	Gut dysbiosis; Metabolic syndrome; Diabetes mellitus; Prebiotics; Probiotics; Postbiotics
Core Tip	Gut microbiome dysbiosis is related to chronic inflammation, insulin resistance, metabolic syndrome, cardiovascular diseases (CVD), and obesity. It is well known that obesity, type 2 diabetes mellitus and CVD are caused or worsened by multiple factors like genetic predisposition, environmental factors, unhealthy high calorie diets, and sedentary lifestyle. However, recent evidence from human and mouse models suggest that the gut microbiome is also an active player in modulation of these metabolic diseases. Hence it is important to review the role of microbiome supplementation that has been shown to improve the gut microbiome in patients with metabolic syndrome.
Publish Date	2023-10-09 11:18
Citation	Antony MA, Chowdhury A, Edem D, Raj R, Nain P, Joglekar M, Verma V, Kant R. Gut microbiome supplementation as therapy for metabolic syndrome. World J Diabetes 2023; 14(10): 1502-1513
URL	https://www.wjgnet.com/1948-9358/full/v14/i10/1502.htm
DOI	https://dx.doi.org/10.4239/wjd.v14.i10.1502

Full Article (PDF)	WJD-14-1502-with-cover.pdf
Full Article (Word)	WJD-14-1502.docx
Manuscript File	86182_Auto_Edited-LM.docx
Answering Reviewers	86182-Answering reviewers.pdf
Audio Core Tip	86182-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	86182-Conflict-of-interest statement.pdf
Copyright License Agreement	86182-Copyright license agreement.pdf
Peer-review Report	86182-Peer-review(s).pdf
Journal Editor-in-Chief Review Report	86182-Journal editor-in-chief review report.pdf
Scientific Misconduct Check	86182-Bing-Fan JR-2.png
Scientific Editor Work List	86182-Scientific editor work list.pdf